Alongside reporting results of its financial year that completed at the end of March, healthcare and pharmaceutical products distributor McKesson announced plans to separate its Medical-Surgical ...

On December 10, Deutsche Bank analyst George Hill raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $904 from $861 and kept a Buy rating on the shares. In a research note, the ...

IRVING, Texas, December 22, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The ...

McKesson (MCK) is one of the three major pharmaceutical drug distribution companies in the United States. It, along with Cardinal Health (CAH) and Cencora (COR), has a dominant position in the market ...

In ordering the additional discovery, U.S. District Judge Nina Gershon pointed out that McKesson—represented by Covington & Burling—had told U.S. Magistrate Judge Steven Tiscione “in the strongest ...

A $152.3 million judgment accepted by Baltimore City in an opioid lawsuit against pharmaceutical companies McKesson and Cencora could be overturned after McKesson filed an appeal. The appeal was filed ...

IRVING, Texas – McKesson is moving forward with a planned spin-off of its Medical-Surgical Solutions business, aiming to bring both organizations into “sharper focus.” The separation is designed to ...

Sept 23 (Reuters) - McKesson (MCK.N), opens new tab on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth ...

McKesson MCK-0.43%decrease; red down pointing triangle updated its targets for fiscal 2026 and beyond as the diversified healthcare services company continues to advance its growth strategy. The ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026.

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026.

IRVING, Texas – McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company. This strategic move is aimed at sharpening McKesson’s focus on higher ...